After finishing at $1.74 in the prior trading day, Revelation Biosciences Inc. (NASDAQ: REVB) closed at $1.91, up 10.09%. In other words, the price has increased by $+0.1750 from its previous closing price. On the day, 2194712 shares were traded. REVB stock price reached its highest trading level at $2.1300 during the session, while it also had its lowest trading level at $1.6300.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Our goal is to gain a better understanding of REVB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Stock Price History:
Over the past 52 weeks, REVB has reached a high of $100.80, while it has fallen to a 52-week low of $1.55. The 50-Day Moving Average of the stock is 5.5801, while the 200-Day Moving Average is calculated to be 12.7315.
The stock has traded on average 179.43K shares per day over the past 3-months and 430.31k shares per day over the last 10 days, according to various share statistics. A total of 21.05M shares are outstanding, with a floating share count of 0.54M. Insiders hold about 59.18% of the company’s shares, while institutions hold 18.50% stake in the company. Shares short for REVB as of Jan 30, 2023 were 31.11k with a Short Ratio of 0.10M, compared to 47.55k on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.63% and a Short% of Float of 5.42%.
Its stock is currently analyzed by 1 different market analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$23.1 and -$23.1 for the fiscal current year, implying an average EPS of -$23.1. EPS for the following year is -$12.95, with 1 analysts recommending between -$12.95 and -$12.95.